Market
Novartis 4Q Sales $12.69B – MarketWatch
[ad_1]
By Cecilia Butini
Novartis AG on Wednesday posted lower sales and profit as it took a hit from generic medicines competition and higher restructuring costs, but increased its dividend for 2022.
The Swiss pharma major posted net profit of $1.47 billion, down from $16.31 billion the year prior, when it benefited from the sale of its investment…
[ad_2]
Source link